The placement of a permanent pacemaker is the definitive treatment for sinus node dysfunction, but not everyone needs this.
Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...
Sanofi & Regeneron’s Dupixent pivotal study meets all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis: Paris Monday, November 10, ...
This article deconstructs the IIH guidelines, contrasting medical management (acetazolamide, topiramate) with the practical ...
A terminally ill man is preparing to marry the love of his life next month as he enters palliative care. Daniel Singleton was ...
ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal ...
Dupixent sBLA accepted for priority review by the US FDA with a target action date of February 28, 2026; if approved, Dupixent would be the first and only medicine indicated specifically for AFRS, ...
Putin met with a representative of Poland's official National Health Program to discuss the possibility of banning the sale ...
YTN anchor Kim Sun-young, who left her husband, the late lawyer Baek Sung-moon, expressed her feelings.On the 1st, anchor Kim posted a message on lawyer Baek's SNS account, "My husband, lawyer Baek ...